top of page

Aspiring to Improve Patients' Lives

NEXT- GENERATION THERAPEUTICS FOR INFLAMMATORY DISEASES

NEXT- GENERATION THERAPEUTICS FOR INFLAMMATORY DISEASES

Aspiring to Improve Patients' Lives

Latest News

June 17, 2026

Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma

May 12, 2026

Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference

May 12, 2026

Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update

See all press releases >>

bottom of page